Masahiro Maeda
Impact in
- Immunology top 5%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- Rheumatology top 2%
- Bone and Dental Protein Studies
Papers in
- Co-authors
- Naofumi YamauchiH NedaHiroshi KuriyamaTatsuya SegawaYoshiro NiitsuNoboru UryuMasao ÔtaNaoki Watanabe
- Journals
- Journal of Biological Chemistry (9 papers)Biochemical and Biophysical Research Communications (9 papers)Gastric Cancer (6 papers)International Journal of Cancer (4 papers)Human Immunology (4 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Masahiro Maeda
174 papers receiving 5.1k citations
Peers
Comparison fields: 5 of 144
- Immunology 903
- Rheumatology 565
- Molecular Biology 2.3k
- Cancer Research 453
- Physiology 710
Countries citing papers authored by Masahiro Maeda
This map shows the geographic impact of Masahiro Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Maeda more than expected).
Fields of papers citing papers by Masahiro Maeda
This network shows the impact of papers produced by Masahiro Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Maeda. The network helps show where Masahiro Maeda may publish in the future.
Co-authors
The 25 scholars most cited alongside Masahiro Maeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2021 | 6 | |
| 5 | 2020 | 3 | |
| 6 | 2019 | 70 | |
| 7 | 2019 | 6 | |
| 8 | [Effective BiRd Therapy after the Addition of Clarithromycin for Lenalidomide and Dexamethasone Resistant Multiple Myeloma Ineligible for Stem Cell Transplantation]. | 2017 | 0 |
| 9 | 2015 | 19 | |
| 10 | 2013 | 13 | |
| 11 | 2011 | 52 | |
| 12 | 2011 | 10 | |
| 13 | 2009 | 18 | |
| 14 | 2008 | 24 | |
| 15 | 2007 | 30 | |
| 16 | 2006 | 84 | |
| 17 | 2004 | 39 | |
| 18 | 2004 | 22 | |
| 19 | 2002 | 14 | |
| 20 | 1992 | 67 |
About Masahiro Maeda
Masahiro Maeda is a scholar working on Microbiology, Gastroenterology, Hematology, Rheumatology and Pulmonary and Respiratory Medicine, having authored 183 papers that have together received 5.2k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (17 papers), Gastric Cancer Management and Outcomes (13 papers), Bone and Dental Protein Studies (12 papers), Epigenetics and DNA Methylation (8 papers), Helicobacter pylori-related gastroenterology studies (7 papers), T-cell and B-cell Immunology (7 papers), Lymphoma Diagnosis and Treatment (7 papers) and dental development and anomalies (7 papers). The work is most often cited by research in Immunology (903 citations), Rheumatology (565 citations), Molecular Biology (2.3k citations), Cancer Research (453 citations) and Physiology (710 citations). Masahiro Maeda has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Naofumi Yamauchi, H Neda, Hiroshi Kuriyama, Tatsuya Segawa, Yoshiro Niitsu, Noboru Uryu, Masao Ôta, Naoki Watanabe, Shigeyuki Kon and K. Tsuji. Their work appears in journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications, Gastric Cancer, International Journal of Cancer and Human Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.